GTS Securities’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,700
Closed -$241K 4357
2024
Q2
$241K Buy
11,700
+1,000
+9% +$21.6K ﹤0.01% 3294
2024
Q1
$265K Sell
10,700
-2,400
-18% -$71.4K ﹤0.01% 3104
2023
Q4
$476K Buy
+13,100
New +$504K ﹤0.01% 2827

Other funds holding PRTA

GTS Securities's PRTA Position: Q2 2024 in Review

GTS Securities sold out of Prothena Corp (PRTA) in Q2 2024, closing a stake of 10,944 shares — an estimated $237K sold.

GTS Securities first reported a position in PRTA in Q1 2024 and held it in 1 quarter. The position peaked at $271K in Q1 2024. 160 funds tracked by Wall St. Rank hold PRTA as of Q2 2024.

  • GTS Securities reported no remaining Prothena Corp position as of Q2 2024 after selling out during the quarter.
  • GTS Securities sold 10,944 Prothena Corp shares in Q2 2024, an estimated $237K.
  • GTS Securities first reported a position in Prothena Corp in Q1 2024 and held it in 1 quarter.
  • GTS Securities's Prothena Corp position peaked at $271K in Q1 2024.
  • 160 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2024.

Based on GTS Securities's 13F filing for Q2 2024, filed 14 Aug 2024.